Prerna Jain + Kshtiji Aggarwal

Industry data shows 40–60% of AI-flagged trial candidates get disqualified on first pass for reasons unrelated to clinical relevance, such as stale protocol versions, exclusion criteria (like medications) that never came up in conversation, and incompletely captured diagnoses. TrialGuard targets exactly those three failure modes.